These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3207854)

  • 1. Elevation of gastric pH with ranitidine does not affect the release characteristics of sustained release ibuprofen tablets.
    Berardi RR; Dressman JB; Elta GH; Szpunar GJ
    Biopharm Drug Dispos; 1988; 9(4):337-47. PubMed ID: 3207854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of raising gastric pH with ranitidine on the absorption and elimination of theophylline from a sustained-release theophylline tablet.
    Betlach CJ; Straughn AB; Meyer MC; Bialer M; Vashi VI; Liebermann P; González MA
    Pharm Res; 1991 Dec; 8(12):1516-9. PubMed ID: 1808616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of pretreatment with ranitidine on the pharmacokinetics and gastrointestinal transit of a sustained-release theophylline preparation].
    Wilson CG; Washington N; Greaves JL; Blackshaw PE; Perkins AC; Barkworth MF; Rehm KD
    Arzneimittelforschung; 1998 May; 48(5A):561-8. PubMed ID: 9676345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of food on gastrointestinal (GI) transit of sustained-release ibuprofen tablets as evaluated by gamma scintigraphy.
    Borin MT; Khare S; Beihn RM; Jay M
    Pharm Res; 1990 Mar; 7(3):304-7. PubMed ID: 2339107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effervescent and standard formulations of ranitidine--a comparison of their pharmacokinetics and pharmacology.
    Watson RG; Johnston BT; Tham TC; Kersey K
    Aliment Pharmacol Ther; 1996 Dec; 10(6):913-8. PubMed ID: 8971288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tablet and effervescent formulations of ranitidine 75 mg and cimetidine 200 mg on gastric acidity and oesophageal acid exposure in healthy humans.
    Bruley des Varannes S; Duquesnoy C; Mamet JP; Slama A; Galmiche JP; Scarpignato C
    Aliment Pharmacol Ther; 1998 Nov; 12(11):1155-61. PubMed ID: 9845405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pretreatment with ranitidine on the pharmacokinetics and gastrointestinal transit of a sustained release theophylline preparation.
    Wilson CG; Washington N; Greaves JL; Blackshaw PE; Perkins AC; Barkworth MF; Rehm KD
    Arzneimittelforschung; 1991 Nov; 41(11):1154-9. PubMed ID: 1810260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two release rates from monolithic carboxymethyl starch tablets: formulation, characterization, and in vitro/in vivo evaluation.
    Le TC; Mateescu MA
    Drug Deliv Transl Res; 2017 Aug; 7(4):516-528. PubMed ID: 28386870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antisecretory effect of the H2-histamine receptor antagonist ranitidine in water-soluble tablets and film-coated tablets. Results of a randomized, placebo-controlled crossover study in humans].
    Witzel L; Röhmel J
    Arzneimittelforschung; 1990 Apr; 40(4):457-9. PubMed ID: 2192716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evaluation of single-unit commercial conventional tablet and sustained-release capsules compared with multiple-unit polystyrene microparticle dosage forms of Ibuprofen.
    Tamilvanan S; Sa B
    AAPS PharmSciTech; 2006 Sep; 7(3):72. PubMed ID: 17025252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.
    Kakuda TN; Falcon RW
    Pharmacotherapy; 2006 Aug; 26(8):1060-8. PubMed ID: 16863482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of ranitidine effervescent tablets and magnesium hydroxide-aluminium oxide on intragastric acidity. A single-centre, randomised, open cross-over study.
    Propst A; Propst T; Judmaier G
    Arzneimittelforschung; 1996 Jun; 46(6):621-4. PubMed ID: 8767354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of ranitidine and famotidine on the intragastric pH profile of healthy subjects. Randomized cross-over trial with ranitidine effervescent tablets (300 mg) versus famotidine film tablets (40 mg) ].
    Löser C; Burlage M; Fölsch UR
    Arzneimittelforschung; 1994 May; 44(5):626-9. PubMed ID: 8024636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single- and Multiple-Dose Pharmacokinetics of Immediate-Release/Extended-Release Ibuprofen Tablets.
    Legg T; Paluch E; Jayawardena S
    Clin Pharmacol Drug Dev; 2017 Jan; 6(1):36-43. PubMed ID: 27364900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of 300 mg of ranitidine, 800 mg of cimetidine and a placebo administered after the evening meal on 24-hour gastric pH in patients with duodenal ulcer].
    Pestiaux A; Ooghe P; Piérard P; Van Cauter J; Ligny G
    Gastroenterol Clin Biol; 1988 Dec; 12(12):941-5. PubMed ID: 3069551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparative effects of lansoprazole, omeprazole, and ranitidine in suppressing gastric acid secretion.
    Blum RA; Shi H; Karol MD; Greski-Rose PA; Hunt RH
    Clin Ther; 1997; 19(5):1013-23. PubMed ID: 9385488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacokinetic comparison of ibuprofen sustained-release tablets given to young and elderly patients.
    Kendall MJ; Jubb R; Bird HA; le Gallez P; Hill J; Taggart AJ; Rau R
    J Clin Pharm Ther; 1990 Feb; 15(1):35-40. PubMed ID: 2318915
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative human study of ibuprofen enantiomer plasma concentrations produced by two commercially available ibuprofen tablets.
    Cox SR; Brown MA; Squires DJ; Murrill EA; Lednicer D; Knuth DW
    Biopharm Drug Dispos; 1988; 9(6):539-49. PubMed ID: 3228575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morning versus evening dosing of ibuprofen using conventional and time-controlled release formulations.
    Halsas M; Hietala J; Veski P; Jürjenson H; Marvola M
    Int J Pharm; 1999 Nov; 189(2):179-85. PubMed ID: 10536246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
    Abdul-Hussein M; Freeman J; Castell D
    Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.